The acquisition of Agatsa Software will be made in two tranches wherein Tranche 1 ₹8 crore would be completed in February 2023 and Tranche 2 up to ₹22 crore is expected to be completed by August 2023
Sun Pharmaceutical Industries Ltd, has entered into agreements to acquire minority stake in Agatsa Software Pvt Ltd and Remidio Innovative Solutions Pvt Ltd which are non-material investments by the Company in the allied areas.